Patents by Inventor Emmanuel Messas

Emmanuel Messas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240090774
    Abstract: System (1) for predicting an at least partial rupture or the detachment of a vascular plaque which could lead to a stroke or for analysing the biomechanical properties of the wall of an internal jugular vein in order to predict a risk of thrombosis, comprising: a monitoring device (2) comprising a temperature sensor (5) configured to measure the temperature of the vascular plaque or the wall of the jugular vein, a vibration sensor (4) configured to measure mechanical waves passing through the vascular plaque and the underlying walls, a motion sensor (6) configured to measure the movements of the plaque or the wall of the jugular vein (6), an electrical sensor configured to measure a parameter related to the electrical impedance of the plaque, an acoustic wave sensor and a calculation unit (10) configured to analyse the data from the monitoring device (2) by artificial intelligence.
    Type: Application
    Filed: January 25, 2022
    Publication date: March 21, 2024
    Inventors: Emmanuel MESSAS, Frédéric SALDMANN
  • Patent number: 10736603
    Abstract: An apparatus for treating or preventing a valvular disease comprises: a ultrasound probe located externally to a heart of patient, able to produce ultrasound waves focused inside the heart and suitable to generate, at a focal spot, a pressure sufficient to result in cavitation, an imaging device for mapping in real time a treatment region of a cardiac valve of the patient, the treatment region comprising at least one leaflet of the cardiac valve, a controller configured for driving the ultrasound probe to emit a sequence of focused ultrasound waves, the controller being further configured for steering the focused ultrasound waves so as to scan the entire treatment region to soften the tissues of the treatment region. A method for treating or preventing valvular disease, carried out using the apparatus is also provided.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: August 11, 2020
    Assignee: CARDIAWAVE
    Inventors: Emmanuel Messas, Mathieu Pernot, Mickael Tanter, Olivier Villemain
  • Publication number: 20180064412
    Abstract: An apparatus for treating or preventing a valvular disease comprises: a ultrasound probe located externally to a heart of patient, able to produce ultrasound waves focused inside the heart and suitable to generate, at a focal spot, a pressure sufficient to result in cavitation, an imaging device for mapping in real time a treatment region of a cardiac valve of the patient, the treatment region comprising at least one leaflet of the cardiac valve, a controller configured for driving the ultrasound probe to emit a sequence of focused ultrasound waves, the controller being further configured for steering the focused ultrasound waves so as to scan the entire treatment region to soften the tissues of the treatment region. A method for treating or preventing valvular disease, carried out using the apparatus is also provided.
    Type: Application
    Filed: April 1, 2016
    Publication date: March 8, 2018
    Inventors: Emmanuel MESSAS, Mathieu PERNOT, Mickael TANTER, Olivier VILLEMAIN
  • Patent number: 8292884
    Abstract: Novel apparatus and minimally invasive methods to treat atrioventricular valve regurgitation that is a result of tethering of chordae attaching atrioventricular valve leaflets to muscles of the heart, such as papillary muscles and muscles in the heart wall, thereby restricting the closure of the leaflets. Catheter embodiments for delivering and positioning chordal severing and elongating instruments are described.
    Type: Grant
    Filed: August 1, 2003
    Date of Patent: October 23, 2012
    Inventors: Robert A. Levine, Emmanuel Messas
  • Publication number: 20060095025
    Abstract: Novel apparatus and minimally invasive methods to treat atrioventricular valve regurgitation that is a result of tethering of chordae attaching atrioventricular valve leaflets to muscles of the heart, such as papillary muscles and muscles in the heart wall, thereby restricting the closure of the leaflets. Catheter embodiments for delivering and positioning chordal severing and elongating instruments are described.
    Type: Application
    Filed: August 1, 2003
    Publication date: May 4, 2006
    Applicant: The General Hospital Corporation
    Inventors: Robert Levine, Emmanuel Messas